ID   MBTP1_RAT               Reviewed;        1052 AA.
AC   Q9WTZ3; G3V7Z2;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 2.
DT   02-OCT-2024, entry version 160.
DE   RecName: Full=Membrane-bound transcription factor site-1 protease;
DE            EC=3.4.21.112 {ECO:0000269|PubMed:9990022};
DE   AltName: Full=Endopeptidase S1P;
DE   AltName: Full=Subtilisin/kexin isozyme 1 {ECO:0000303|PubMed:9990022};
DE            Short=SKI-1 {ECO:0000303|PubMed:9990022};
DE   Flags: Precursor;
GN   Name=Mbtps1; Synonyms=S1p, Ski1 {ECO:0000303|PubMed:9990022};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Adrenal gland;
RX   PubMed=9990022; DOI=10.1073/pnas.96.4.1321;
RA   Seidah N.G., Mowla S.J., Hamelin J., Mamarbachi A.M., Benjannet S.,
RA   Toure B.B., Basak A., Munzer J.S., Marcinkiewicz J., Zhong M.,
RA   Barale J.-C., Lazure C., Murphy R.A., Chretien M., Marcinkiewicz M.;
RT   "Mammalian subtilisin/kexin isozyme SKI-1: a widely expressed proprotein
RT   convertase with a unique cleavage specificity and cellular localization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:1321-1326(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Serine protease that cleaves after hydrophobic or small
CC       residues, provided that Arg or Lys is in position P4: known substrates
CC       include SREBF1/SREBP1, SREBF2/SREBP2, BDNF, GNPTAB, ATF6, ATF6B and
CC       FAM20C. Cleaves substrates after Arg-Ser-Val-Leu (SREBP2), Arg-His-Leu-
CC       Leu (ATF6), Arg-Gly-Leu-Thr (BDNF) and its own propeptide after Arg-
CC       Arg-Leu-Leu. Catalyzes the first step in the proteolytic activation of
CC       the sterol regulatory element-binding proteins (SREBPs) SREBF1/SREBP1
CC       and SREBF2/SREBP2. Also mediates the first step in the proteolytic
CC       activation of the cyclic AMP-dependent transcription factor ATF-6 (ATF6
CC       and ATF6B). Mediates the protein cleavage of GNPTAB into subunit alpha
CC       and beta, thereby participating in biogenesis of lysosomes. Cleaves the
CC       propeptide from FAM20C which is required for FAM20C secretion from the
CC       Golgi apparatus membrane and for enhancement of FAM20C kinase activity,
CC       promoting osteoblast differentiation and biomineralization. Involved in
CC       the regulation of M6P-dependent Golgi-to-lysosome trafficking of
CC       lysosomal enzymes. It is required for the activation of CREB3L2/BBF2H7,
CC       a transcriptional activator of MIA3/TANGO and other genes controlling
CC       mega vesicle formation. Therefore, it plays a key role in the
CC       regulation of mega vesicle-mediated collagen trafficking. In astrocytes
CC       and osteoblasts, upon DNA damage and ER stress, mediates the first step
CC       of the regulated intramembrane proteolytic activation of the
CC       transcription factor CREB3L1, leading to the inhibition of cell-cycle
CC       progression. {ECO:0000250|UniProtKB:Q14703}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Processes precursors containing basic and
CC         hydrophobic/aliphatic residues at P4 and P2, respectively, with a
CC         relatively relaxed acceptance of amino acids at P1 and P3.;
CC         EC=3.4.21.112; Evidence={ECO:0000269|PubMed:9990022};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:Q14703};
CC   -!- ACTIVITY REGULATION: Inhibited by divalent copper and zinc ions, but
CC       not by nickel or cobalt. Inhibited by its prosegment, but not smaller
CC       fragments. Inhibited by 4-(2-aminoethyl)benzenesulfonyl fluoride
CC       (AEBSF), a serine protease inhibitor. {ECO:0000250|UniProtKB:Q14703}.
CC   -!- SUBUNIT: Interacts with LYSET; this interaction bridges GNPTAB to
CC       MBTPS1. {ECO:0000250|UniProtKB:Q14703}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q14703}; Single-pass type I membrane protein
CC       {ECO:0000255}. Golgi apparatus membrane {ECO:0000269|PubMed:9990022};
CC       Single-pass type I membrane protein {ECO:0000255}. Note=May sort to
CC       other organelles, including lysosomal and/or endosomal compartments.
CC       {ECO:0000250|UniProtKB:Q14703}.
CC   -!- TISSUE SPECIFICITY: Widely expressed (PubMed:9990022). In adult rat,
CC       highly expressed in anterior pituitary, thyroid and adrenal glands and
CC       in liver (PubMed:9990022). In 2-day old rat, detected in developing
CC       skin, striated muscles, cardiac muscles, bones, teeth and internal
CC       organs (PubMed:9990022). Highly expressed in retina, cerebellum,
CC       pituitary, submaxillary, thyroid and adrenal glands, molars, thymus,
CC       kidney and intestine (PubMed:9990022). {ECO:0000269|PubMed:9990022}.
CC   -!- PTM: The 148 kDa zymogen is processed progressively into two membrane-
CC       bound 120 and 106 kDa forms in the endoplasmic reticulum, and late into
CC       a secreted 98 kDa form. The propeptide is autocatalytically removed
CC       through an intramolecular cleavage after Leu-186. Further cleavage
CC       generates 14, 10, and 8 kDa intermediates.
CC       {ECO:0000250|UniProtKB:Q14703}.
CC   -!- SIMILARITY: Belongs to the peptidase S8 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF094821; AAD27011.1; -; mRNA.
DR   EMBL; AABR06099111; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473972; EDL92670.1; -; Genomic_DNA.
DR   RefSeq; NP_446021.1; NM_053569.1.
DR   RefSeq; XP_006255785.1; XM_006255723.3.
DR   AlphaFoldDB; Q9WTZ3; -.
DR   SMR; Q9WTZ3; -.
DR   BioGRID; 250155; 1.
DR   IntAct; Q9WTZ3; 1.
DR   MINT; Q9WTZ3; -.
DR   STRING; 10116.ENSRNOP00000071317; -.
DR   MEROPS; S08.063; -.
DR   GlyCosmos; Q9WTZ3; 6 sites, No reported glycans.
DR   GlyGen; Q9WTZ3; 6 sites.
DR   PhosphoSitePlus; Q9WTZ3; -.
DR   PaxDb; 10116-ENSRNOP00000020838; -.
DR   Ensembl; ENSRNOT00000020838.8; ENSRNOP00000020838.4; ENSRNOG00000015173.8.
DR   Ensembl; ENSRNOT00055035879; ENSRNOP00055029136; ENSRNOG00055020994.
DR   Ensembl; ENSRNOT00060039310; ENSRNOP00060032507; ENSRNOG00060022648.
DR   Ensembl; ENSRNOT00065010269; ENSRNOP00065007502; ENSRNOG00065006633.
DR   GeneID; 89842; -.
DR   KEGG; rno:89842; -.
DR   UCSC; RGD:70935; rat.
DR   AGR; RGD:70935; -.
DR   CTD; 8720; -.
DR   RGD; 70935; Mbtps1.
DR   eggNOG; KOG4266; Eukaryota.
DR   GeneTree; ENSGT00490000043404; -.
DR   InParanoid; Q9WTZ3; -.
DR   OrthoDB; 5606at2759; -.
DR   TreeFam; TF324501; -.
DR   BRENDA; 3.4.21.112; 5301.
DR   Reactome; R-RNO-1655829; Regulation of cholesterol biosynthesis by SREBP (SREBF).
DR   Reactome; R-RNO-381033; ATF6 (ATF6-alpha) activates chaperones.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8874177; ATF6B (ATF6-beta) activates chaperones.
DR   Reactome; R-RNO-8874211; CREB3 factors activate genes.
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:Q9WTZ3; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Proteomes; UP000234681; Chromosome 19.
DR   Bgee; ENSRNOG00000015173; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; ISO:RGD.
DR   GO; GO:0005795; C:Golgi stack; ISO:RGD.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0007040; P:lysosome organization; ISS:UniProtKB.
DR   GO; GO:0031293; P:membrane protein intracellular domain proteolysis; ISO:RGD.
DR   GO; GO:0007095; P:mitotic G2 DNA damage checkpoint signaling; ISO:RGD.
DR   GO; GO:0051604; P:protein maturation; ISO:RGD.
DR   GO; GO:0016485; P:protein processing; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; ISS:UniProtKB.
DR   GO; GO:0060627; P:regulation of vesicle-mediated transport; ISO:RGD.
DR   CDD; cd07479; Peptidases_S8_SKI-1_like; 1.
DR   Gene3D; 3.40.50.200; Peptidase S8/S53 domain; 1.
DR   InterPro; IPR000209; Peptidase_S8/S53_dom.
DR   InterPro; IPR036852; Peptidase_S8/S53_dom_sf.
DR   InterPro; IPR022398; Peptidase_S8_His-AS.
DR   InterPro; IPR023828; Peptidase_S8_Ser-AS.
DR   InterPro; IPR050131; Peptidase_S8_subtilisin-like.
DR   InterPro; IPR015500; Peptidase_S8_subtilisin-rel.
DR   InterPro; IPR034185; Site-1_peptidase_cat_dom.
DR   PANTHER; PTHR43806:SF7; MEMBRANE-BOUND TRANSCRIPTION FACTOR SITE-1 PROTEASE; 1.
DR   PANTHER; PTHR43806; PEPTIDASE S8; 1.
DR   Pfam; PF23001; MBTP1_N; 1.
DR   Pfam; PF00082; Peptidase_S8; 1.
DR   PRINTS; PR00723; SUBTILISIN.
DR   SUPFAM; SSF52743; Subtilisin-like; 1.
DR   PROSITE; PS51892; SUBTILASE; 1.
DR   PROSITE; PS00137; SUBTILASE_HIS; 1.
DR   PROSITE; PS00138; SUBTILASE_SER; 1.
PE   1: Evidence at protein level;
KW   Autocatalytic cleavage; Calcium; Cholesterol metabolism;
KW   Endoplasmic reticulum; Glycoprotein; Golgi apparatus; Hydrolase;
KW   Lipid metabolism; Membrane; Phosphoprotein; Protease; Reference proteome;
KW   Serine protease; Signal; Steroid metabolism; Sterol metabolism;
KW   Transmembrane; Transmembrane helix; Zymogen.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   PROPEP          18..186
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000027055"
FT   CHAIN           187..1052
FT                   /note="Membrane-bound transcription factor site-1 protease"
FT                   /id="PRO_0000027056"
FT   TOPO_DOM        187..999
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1000..1022
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1023..1052
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          190..472
FT                   /note="Peptidase S8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   REGION          877..900
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1026..1052
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        218
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   ACT_SITE        249
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   ACT_SITE        414
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   SITE            186..187
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14703"
FT   MOD_RES         168
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14703"
FT   CARBOHYD        148
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        236
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        305
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        515
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        728
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        939
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        301
FT                   /note="I -> M (in Ref. 1; AAD27011)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1052 AA;  117462 MW;  417A6FEE4DEAB2B6 CRC64;
     MKLVNIWLLL LVVLLCGKKH LGDRLGKKAF EKAPCPSCSH LTLKVEFSST VVEYEYIVAF
     NGYFTAKARN SFISSALKSS EVDNWRIIPR NNPSSDYPSD FEVIQIKEKQ KAGLLTLEDH
     PNIKRVTPQR KVFRSLKFAE SDPIVPCNET RWSQKWQSSR PLKRASLSLG SGFWHATGRH
     SSRRLLRAIP RQVAQTLQAD VLWQMGYTGA NVRVAVFDTG LSEKHPHFKN VKERTNWTNE
     RTLDDGLGHG TFVAGVIASM RECQGFAPDA ELHIFRVFTN NQVSYTSWFL DAFNYAILKK
     IDVLNLSIGG PDFMDHPFVD KVWELTANNV IMVSAIGNDG PLYGTLNNPA DQMDVIGVGG
     IDFEDNIARF SSRGMTTWEL PGGYGRVKPD IVTYGAGVRG SGVKGGCRAL SGTSVASPVV
     AGAVTLLVST VQKRELVNPA SVKQALIASA RRLPGVNMFE QGHGKLDLLR AYQILSSYKP
     QASLSPSYID LTECPYMWPY CSQPIYYGGM PTIVNVTILN GMGVTGRIVD KPEWRPYLPQ
     NGDNIEVAFS YSSVLWPWSG YLAISISVTK KAASWEGIAQ GHIMITVASP AETELKNGAE
     HTSTVKLPIK VKIIPTPPRS KRVLWDQYHN LRYPPGYFPR DNLRMKNDPL DWNGDHVHTN
     FRDMYQHLRS MGYFVEVLGA PFTCFDATQY GTLLMVDSEE EYFPEEIAKL RRDVDNGLSL
     VVFSDWYNTS VMRKVKFYDE NTRQWWMPDT GGANVPALNE LLSVWNMGFS DGLYEGEFAL
     ANHDMYYASG CSIARFPEDG VVITQTFKDQ GLEVLKQETA VVDNVPILGL YQIPAEGGGR
     IVLYGDSNCL DDSHRQKDCF WLLDALLQYT SYGVTPPSLS HSGNRQRPPS GAGLAPPERM
     EGNHLHRYSK VLEAHLGDPK PRPLPACPHL SWAKPQPLNE TAPSNLWKHQ KLLSIDLDKV
     VLPNFRSNRP QVRPLSPGES GAWDIPGGIM PGRYNQEVGQ TIPVFAFLGA MVALAFFVVQ
     ISKAKSRPKR RRPRAKRPQL AQQAHPARTP SV
//
